The Research Library.
Neutral, factual overviews of each peptide and the areas in which it is studied. For research reference only.
Investigational peptide
Retatrutide
Retatrutide is a peptide-based investigational compound that acts as an agonist at the GLP-1, GIP and glucagon receptors. Scientific research has examined its effects on metabolic regulation and energy balance. It remains subject to clinical investigation and should not be presented as an approved treatment.
View productCopper-binding tripeptide
GHK-Cu (Copper Tripeptide-1)
GHK-Cu is a naturally occurring copper complex of the tripeptide glycyl-L-histidyl-L-lysine. It has been studied in laboratory models examining cellular signalling, extracellular matrix components and tissue biology.
View productSynthetic α-MSH analogue
MT2 — Melanotan II
Melanotan II is a synthetic analogue of alpha-melanocyte-stimulating hormone. It has been studied for its interactions with melanocortin receptors and associated biological signalling pathways.
View productModified growth factor analogue
IGF-1 LR3 (Long R3 IGF-1)
IGF-1 LR3 is a modified form of insulin-like growth factor 1. The analogue has been studied in experimental systems involving IGF receptor interactions and cellular signalling.
View productExperimental peptide
BPC-157 (Body Protection Compound-157)
BPC-157 is a synthetic peptide studied predominantly in preclinical experimental models. Research has examined its interactions with biological processes associated with tissue responses and cellular signalling. Human clinical evidence remains limited.
View productMitochondrial-derived peptide
MOTS-C
MOTS-C is a peptide encoded within the mitochondrial genome. Experimental research has examined its potential involvement in metabolic signalling, cellular stress responses and energy regulation.
View product